Balance Sheet Insights: Ocuphire Pharma Inc (OCUP)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Ocuphire Pharma Inc (NASDAQ: OCUP) closed at $1.17 down -12.03% from its previous closing price of $1.33. In other words, the price has decreased by -$12.03 from its previous closing price. On the day, 0.68 million shares were traded. OCUP stock price reached its highest trading level at $1.36 during the session, while it also had its lowest trading level at $1.0715.

Ratios:

For a deeper understanding of Ocuphire Pharma Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.68 and its Current Ratio is at 10.68. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 22 ’24 when Jayagopal Ashwath bought 3,500 shares for $1.76 per share. The transaction valued at 6,178 led to the insider holds 78,500 shares of the business.

Magrath George bought 5,000 shares of OCUP for $8,772 on May 17 ’24. The Chief Executive Officer now owns 430,000 shares after completing the transaction at $1.75 per share. On Mar 21 ’24, another insider, SCHACHLE JOSEPH K, who serves as the Chief Operating Officer of the company, bought 2,000 shares for $2.05 each. As a result, the insider paid 4,100 and bolstered with 2,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OCUP now has a Market Capitalization of 30652126 and an Enterprise Value of -10761821. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.86 while its Price-to-Book (P/B) ratio in mrq is 0.75. Its current Enterprise Value per Revenue stands at -0.654 whereas that against EBITDA is 0.714.

Stock Price History:

Over the past 52 weeks, OCUP has reached a high of $3.40, while it has fallen to a 52-week low of $1.15. The 50-Day Moving Average of the stock is -8.96%, while the 200-Day Moving Average is calculated to be -36.46%.

Shares Statistics:

For the past three months, OCUP has traded an average of 127.29K shares per day and 153980 over the past ten days. A total of 23.98M shares are outstanding, with a floating share count of 23.69M. Insiders hold about 9.58% of the company’s shares, while institutions hold 10.38% stake in the company. Shares short for OCUP as of 1727654400 were 930639 with a Short Ratio of 7.31, compared to 1724976000 on 1027720. Therefore, it implies a Short% of Shares Outstanding of 930639 and a Short% of Float of 3.74.

Most Popular